Join SDI’s next webinar on Wednesday, January 21st, 2026 (1pm – 2pm EST).This live event will feature Dr. Mark Schleiss, Professor of Pediatrics, University of Minnesota Medical School, and Jack Hysell, Director, Solutions Engineering at Primary.Health.
This session will provide attendees with a foundational understanding of the public health impact of congenital cytomegalovirus (cCMV) and its significance as a leading cause of newborn morbidity in the United States. Speakers will review the clinical purpose and economic value of cCMV screening within established newborn screening programs, and explain why saliva testing is preferred over dried blood spot methods for accurate detection.
The discussion will also cover saliva-based PCR testing—including methodology, proper collection techniques, and performance compared to urine and dried blood spot testing—as well as the clinical management of infants who screen positive, from confirmatory testing and ongoing monitoring to treatment considerations and family counseling.
Register today to learn best practices for saliva-based cCMV screening and follow-up care.